Related Experiment Video

Updated: Aug 14, 2026

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
07:57

Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

Published on: August 25, 2022

Oligohydramnios: a review

J F Peipert1, A E Donnenfeld

  • 1Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia.

Obstetrical & Gynecological Survey
|June 1, 1991
PubMed

Insights

Oligohydramnios, a pregnancy complication, can lead to severe fetal issues like pulmonary hypoplasia. Early identification of the cause and close monitoring are crucial for managing this condition.

Area of Science:

  • Obstetrics and Gynecology
  • Fetal Medicine

Background:

  • Oligohydramnios, characterized by low amniotic fluid, is a frequent pregnancy complication.
  • It is associated with various etiologies, including congenital anomalies and postterm gestation.

Purpose of the Study:

  • To summarize the causes, consequences, and management of oligohydramnios.
  • To highlight the importance of identifying the etiology and implementing antenatal surveillance.

Main Methods:

  • Literature review of oligohydramnios causes and sequelae.
  • Analysis of perinatal outcomes in pregnancies with oligohydramnios.

Main Results:

  • Oligohydramnios can result from congenital anomalies, growth retardation, ruptured membranes, drugs, or postterm pregnancy.
  • Severe consequences include pulmonary hypoplasia and fetal compression syndrome.
  • Increased perinatal morbidity and mortality are linked to oligohydramnios.

Conclusions:

  • Effective management necessitates a comprehensive search for the underlying cause of reduced amniotic fluid.
  • Close antenatal surveillance is essential for optimizing outcomes in pregnancies affected by oligohydramnios.

More Related Videos

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...